Document Detail


Ice mapping during tachycardia in close proximity to the AV node is safe and offers advantages for transcatheter ablation procedures.
MedLine Citation:
PMID:  18214124     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Ablation during ongoing orthodromic reentry tachycardia (AVRT) and atrioventricular nodal reentry tachycardia (AVNRT) is not recommended using radiofrequency energy when the arrhythmia substrate is located in close proximity to the atrioventricular (AV) node due to a significant risk for inadvertent AV block. The aim of the study is to test the feasibility of ice mapping during tachycardias involving arrhythmia substrate located in close proximity to the AV node. METHODS: This was a single-centre, prospective, randomized study. A total of 65 patients was screened and 30 patients with supraventricular arrhythmias were assigned either to a cryo or RF energy group after diagnosis of AVNRT (17 pts) or AVRT (13 pts) with an anteroseptal accessory pathway. RF ablation was performed using standard ablation techniques. In the cryo group, ice mapping was performed during tachycardia with cooling of the catheter tip temperature to a maximum of -40 degrees C. Ablation was performed only if ice mapping terminated the tachycardia without prolongation of the AV conduction. RESULTS: The overall acute success rate was 84%, and was not different in the cryo and RF groups (85% vs. 82.4%, P = 0.43). Both fluoroscopy and the procedure times were comparable. There was a marked reduction in the mean number of applications in the cryo group [2 (1-6) vs. 7 (1-41), P = 0.002]. In one patient ablation was not attempted in the cryo group because of AV prolongation, and in two patients temporary second-degree AV block was observed in the RF group. After 12 months follow-up the long-term success rate was similar between the two groups. CONCLUSIONS: (I) Ice mapping is a feasible method to determine the exact location of accessory pathways and of the slow pathway during tachycardia. (2) Ice mapping performed during tachycardia causes less ablation lesions without increasing the procedure and fluoroscopy times.
Authors:
Attila Kardos; Dora Paprika; Tchavdar Shalganov; Radu Vatasescu; Csaba Foldesi; Laszlo Kornyei; Tamas Szili-Torok
Related Documents :
15728604 - Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation.
16087104 - Complete pulmonary vein isolation guided by three-dimensional electroanatomical mapping...
20444474 - Newly designed flexible electrode for laparoscopic radiofrequency ablation: ex vivo and...
3136634 - Restoration of sinus rhythm with flecainide in patients with atrial fibrillation.
6707844 - Comparison of two feeding regimens following acute gastroenteritis in infancy.
10147354 - Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Acta cardiologica     Volume:  62     ISSN:  0001-5385     ISO Abbreviation:  Acta Cardiol     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2008-01-24     Completed Date:  2008-02-26     Revised Date:  2009-06-11    
Medline Journal Info:
Nlm Unique ID:  0370570     Medline TA:  Acta Cardiol     Country:  Belgium    
Other Details:
Languages:  eng     Pagination:  587-91     Citation Subset:  IM    
Affiliation:
Gottsegen Gyorgy Hungarian Institute of Cardiology, Budapest, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Atrioventricular Node* / surgery
Catheter Ablation*
Child
Cryosurgery*
Female
Follow-Up Studies
Humans
Male
Middle Aged
Prospective Studies
Tachycardia, Atrioventricular Nodal Reentry* / diagnosis,  surgery,  therapy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in...
Next Document:  Effects of atypical pneumonia agents on progression of atherosclerosis and acute coronary syndrome.